Radiobiology in Radiotherapy

  • Norman M. Bleehen
Conference proceedings

Table of contents

  1. Front Matter
    Pages i-xi
  2. P. R. Twentyman
    Pages 9-15
  3. G. Ross, J. R. Yarnold
    Pages 31-45
  4. R. J. Berry
    Pages 47-52
  5. M. V. Williams
    Pages 59-71
  6. A. Horwich, P. Blake, G. G. Steel
    Pages 81-93
  7. L. S. Constine, P. Rubin
    Pages 95-121
  8. A. Barrett
    Pages 123-127
  9. D. K. Bewley
    Pages 129-135
  10. H. M. Warenius, R. D. Errington
    Pages 137-151
  11. H. Bartelink, A. C. Begg, L. Dewit, F. A. Stewart
    Pages 177-199
  12. S. B. Field
    Pages 201-208
  13. N. M. Bleehen, G. C. W. Howard
    Pages 209-231
  14. L. W. Brady, D. V. Woo, A. M. Markoe, H. Koprowski, C. T. Miyamoto
    Pages 233-242
  15. Back Matter
    Pages 243-248

About these proceedings


The ninth annual multidisciplinary symposium on clinical oncology organized by the Royal College of Radiologists was jointly arranged with the International Society for Radiation Oncology. It was held in London in February 1987 and discussed the biological and clinical basis of the effects of radiotherapy. Wherever possible lectures by an experimental scientist were paired with those of a clinical scientist in order to emphasize clinical relevance. It is hoped that this has resulted in a widely balanced view of the subject. The volume presents an updated version of these subjects based on those talks. After surgery, radiotherapy is the main treatment used in the management of patients with cancer. Its empirical success when first introduced is now backed up by a wealth of laboratory, clinical and experimental experience. New techniques for adminis­ tering the conventional X-ray therapy have been supplemented by methods which can be used to modify the radiation response. These include changes in dose rate or fractionation, and combined modality treatments including sensitization by drugs or heat. Other types of radiation, such as neutrons and other particles, are also now available which have enhanced physical and biological advantages.


cancer cells diagnosis hyperthermia radiation radiobiology radiotherapy tissue tumor

Editors and affiliations

  • Norman M. Bleehen
    • 1
  1. 1.University of Cambridge School of Clinical Medicine, Department of Clinical Oncology and RadiotherapeuticsAddenbrooke’s HospitalCambridgeUK

Bibliographic information

Industry Sectors
Health & Hospitals
Oncology & Hematology